Treatment of sarcoidosis using placental stem cells

Disclosed is the use of CD10+, CD34-, CD105+, CD200+ placental stem cells in the manufacture of a medicament for treating an individual having sarcoidosis, wherein said sarcoidosis is systemic sarcoidosis, cutaneous sarcoidosis, Löfgren's syndrome, neurosarcoidosis, cardiac sarcoidosis, or ocul...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	LIANG BITAO, EDINGER JAMES, ZHANG XIAOKUI, FISCHKOFF STEVEN, MARTIN PHILIPPE, JANKOVIC VLADIMIR, RAY CYNTHIA, FRANCKI ALEKSANDER
Format:	Patent
Sprache:	eng
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Disclosed is the use of CD10+, CD34-, CD105+, CD200+ placental stem cells in the manufacture of a medicament for treating an individual having sarcoidosis, wherein said sarcoidosis is systemic sarcoidosis, cutaneous sarcoidosis, Löfgren's syndrome, neurosarcoidosis, cardiac sarcoidosis, or ocular sarcoidosis.